The FTSE 100’s biggest company is crushing the coronavirus. I’d buy its shares today!

This UK household name is powering ahead during the Covid-19 crisis. I’d buy this FTSE 100 share for stability, dividends, and growth.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

As I wrote towards the end of May, the old FTSE 100 is dead. Four months on from the steepest crash in its history and the UK’s main market index keeps evolving.

The FTSE 100’s new king

Until recently, the surging share price of UK pharma giant AstraZeneca (LSE: AZN) had made it the FTSE 100’s new king. The shares are up a quarter (25.4%) over the past 12 months, driven by enthusiasm about an exciting drugs pipeline. The firm is also a leading candidate to develop a Covid-19 vaccine, briefly driving its share price above £100.

The FTSE 100’s new new king

AstraZeneca’s shares have dropped back about 15% from their all-time high and currently trade at around £86.56. This values the UK’s leading drugmaker at a tidy £113.1bn.

However, thanks to a recent share surge elsewhere, the FTSE 100 has yet another new king. Currently, the FTSE 100’s biggest business by market value is Anglo-Dutch household name Unilever (LSE: ULVR).

As I write, Unilever’s share price hovers around £47.14, valuing this global leader at £122bn – or £8.9bn more than AstraZeneca.

Unilever is built on enormous scale

Here’s a single number to blow you away. Around 2.5bn people – or one in three of the world population – use Unilever products. To me, that’s simply mind-blowing.

Unilever has had a long time to grow. Its origins date back to 1871, when it was built on making butter and margarine. It then moved into manufacturing soap, detergents, and a whole host of other household products.

Today, Unilever has over 400 household brands in its cupboard – far too many to list. In the UK, our favourites include Domestos (cleanser), Dove (soap), Hellmann’s (mayo), Knorr (soup), Lipton (tea), Lynx (deodorant), Magnum (ice cream), and Surf (laundry detergent) – and this list goes on and on.

A FTSE 100 colossus

While other businesses have crashed due to the coronavirus, Unilever’s market leadership in cleansing and hygiene products has proved vital. Last week, the FTSE 100’s #1 unveiled better-than-expected quarterly sales, down only 0.3% in the deepest recession in British history. This caused a one-day surge of nearly 8% in its share price.

At £47.14, Unilever shares are down just 3.8% over the past 12 months, while the wider FTSE 100 has crashed by a fifth. Unilever’s 52-week high of £53.33 was set on 4 September 2019, so it’s slipped 11.6% since. Then again, Unilever shares were an absolute bargain on 16 March, when they slumped to just £35.83. That was a golden opportunity to buy into a world-class business at a low price.

Unilever combines stability, income, and growth

Today, Unilever shares are not so cheap as in March, trading on a price-to-earnings ratio of 22.9 and a dividend yield of 3.1%. Then again, the king of the FTSE 100 keeps churning out quarterly cash dividends, unlike dozens of big firms that have cut, suspended, or cancelled payouts.

Buy Unilever shares before 6 August and you’ll be entitled to the next quarterly dividend of 36.98p, paid on 9 September. Then sit back and watch future dividends come rolling in forever. That’s why I’d buy and hold this FTSE 100 star’s shares today.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Cliffdarcy has no position in any of the shares mentioned. The Motley Fool UK has recommended Unilever. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Investing regularly could help me create a passive income stream worth £312 per week

Sumayya Mansoor breaks down how she would aim to build a passive income stream by investing in quality dividend shares…

Read more »

Investing Articles

1 wonderful FTSE 100 stock I’d love to buy

This Fool explains why this FTSE 100 stock looks like an excellent stock for her and her holdings and details…

Read more »

Investing Articles

This FTSE 250 stock might be an underrated gem for investors to consider buying

Our writer explains how this FTSE 250 stock is looking to turn around its fortunes and why investors should be…

Read more »

Young black colleagues high-fiving each other at work
Investing Articles

My favourite AIM growth stock is up 10% after today’s results and 991% over 5 years!

Harvey Jones had been looking forward to today's results from this AIM-listed growth stock for weeks and they haven't disappointed.…

Read more »

Blue NIO sports car in Oslo showroom
Investing Articles

Up 32% in a month, is NIO stock in recovery mode?

NIO has long been one of the most speculative stocks out there. But after a 32% rise in a month,…

Read more »

Investing Articles

Where will the National Grid share price be in 5 years?

The renewable energy sector is expected to see enormous growth over the coming years. So what does this mean for…

Read more »

Investing Articles

As short interest increases by 35%, is the ITV share price in trouble?

Recent market events shows that short interest in a company matters, so as this grows substantially for ITV, is the…

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Investing Articles

Here’s the last investment I’d sell from my Stocks and Shares ISA

There are various reasons to sell an investment. But Stephen Wright has one investment in his Stocks and Shares ISA…

Read more »